Rapamycin treatment for Alzheimer’s disease and related dementias: a pilot phase 1 clinical trial
Abstract Background Rapamycin has been shown to extend lifespan and acts on pathologies underlying Alzheimer’s disease and related dementias in animal models. However, rapamycin’s clinical application remains underexplored. Methods We conducted a single-site open-label phase 1 clinical trial (Clinic...
Збережено в:
| Автори: | , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Nature Portfolio
2025-05-01
|
| Серія: | Communications Medicine |
| Онлайн доступ: | https://doi.org/10.1038/s43856-025-00904-9 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|